Diego Cigna

Diego Cigna

Auto-generated profile, based on publicly available information

Diego Cigna

Institute of Biomedicine and Molecular Immunology (IBIM), CNR a , Palermo, Italy+39 091 680 9122 +39 091 680 9193

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 1993 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
CCCalogero Caruso
Calogero Caruso
Giuseppina CandoreGiuseppina Candore
Giuseppina Candore
DCDiego Cigna
Diego Cigna
ACAntonio Tobia Colucci
Antonio Tobia Colucci
MMMaria Assunta Modica
Maria Assunta Modica
A NUMBER of receptors for growth factors and differentiation antigens have been found to be secreted or released by cells. Following mononuclear cell (MNC) activation and interleukin‐2 receptor (IL‐2R) expression, a soluble form of the Alpha;‐chain of IL‐2R (sIL‐2R) is released. The sIL‐2R has been shown to be present in the culture supernatants of activated MNCs as well as in normal sera and, in higher amounts, in sera from subjects affected by several diseases including neoplastic, infectious and autoimmune ones, and in sera from transplanted patients suffering allograft rejection. The blood sIL‐2R levels depend on the number of producing cells and the number of molecules per cell, so that sIL‐2R blood values may represent an index of the number and the functional state of producing cells, both normal and neoplastic. Thus, monitoring of the immune system, mostly T‐cells and haematological malignancies might be targets for the measurement of sIL‐2R. Since many conditions may influence sIL‐2R production, little diagnostic use may result from these measurements. However, since blood sIL‐2R levels may correlate with disease progression and/or response to therapy, their measurement may be a useful index of activity and extent of disease. The precise biological role of the soluble form of the IL‐2R is still a matter of debate. However, we know that increased sIL‐2R levels may be observed in association with several immunological abnormalities and that sIL‐2R is able to bind IL‐2. It is conceivable then that in these conditions the excess sIL‐2R released in vivo by activated lymphoid cells or by neoplastic cells may somehow regulate IL‐2‐dependent processes. On the other hand, it cannot exclude that sIL‐2R is a by‐product without biological significance. Finally, it is puzzling that in many conditions in which an increase of blood sIL‐2R values has been observed, MNCs display a decreased in vitro capacity to produce sIL‐2R. These seemingly contrasting findings are discussed in the light of the data showing that sIL‐2R production correlates with IL‐2 production.

1 March 1996 in Immunologic Research
Verified
Journal Article
Closed access
PDF file
CCCalogero Caruso
Calogero Caruso
Giuseppina CandoreGiuseppina Candore
Giuseppina Candore
DCDiego Cigna
Diego Cigna
GLGabriele Di Lorenzo
Gabriele Di Lorenzo
GSGuido Sireci
Guido Sireci
ASAlfredo Salerno
Alfredo Salerno

1 April 1999 in Mechanisms of Ageing and Development
Verified
Journal Article
Closed access
GLGabriele Di Lorenzo
Gabriele Di Lorenzo
Carmela BalistreriCarmela Balistreri
Carmela Balistreri
Giuseppina CandoreGiuseppina Candore
Giuseppina Candore
DCDiego Cigna
Diego Cigna
ACAlfredo Colombo
Alfredo Colombo
CCCalogero Caruso
Calogero Caruso

1 January 1993 in Autoimmunity
Verified
Journal Article
Closed access
PDF file
Giuseppina CandoreGiuseppina Candore
Giuseppina Candore
GLGabriele Di Lorenzo
Gabriele Di Lorenzo
MMMarcello Melluso
Marcello Melluso
DCDiego Cigna
Diego Cigna
ACAntonio Tobia Colucci
Antonio Tobia Colucci
Marco MalavoltaMarco Malavolta
Marco Malavolta
It is well known that ageing is associated with various alterations of the lymphoid cell functions. Although both B and T cell are affected, the last appear to be more sensitive to ageing process. During the past years, to gain insight into the mechanism(s) of this impairment, effort has been centered on the helper T cells specifically engaged in the production of interleukin-2 (IL-2) because of the pivotal role played by this cytokine in the activation of several immune functions. The results have demonstrated that the ability to produce IL-2 declines with age. In this paper we report the results of a study performed to determine the influence of age on the capacity to produce γ-interferon (γ-IFN), interleukin-4 (IL-4) and interleukin-6 (IL-6). Mononuclear cells from young and old subjects were assessed for cytokine producing capacity in response to phytohaemoagglutinin stimulation. A significant decrease of γ-IFN production by old subjects has been observed. No significant difference was instead observed between the old subjects and the young ones as regards IL-4 and IL-6 production. We suggest that this imbalanced cytokine production may well account for the pattern of immune response which may be observed in elderly, i.e. a normal or increased humoral response in face of a low T cell immune responsiveness.

1 October 2002 in The Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
NCNadia Caccamo
Nadia Caccamo
SMSalvatore Milano
Salvatore Milano
CSCaterina Di Sano
Caterina Di Sano
DCDiego Cigna
Diego Cigna
JIJuraj Ivanyi
Juraj Ivanyi
ASAlfredo Salerno
Alfredo Salerno
CD8+ T cells could make an important contribution to protection against tuberculosis (TB), but the antigenic determinants recognized in the context o

1 November 2013 in Cell Stress and Chaperones
Verified
Journal Article
Open access
PDF file
EPElisabetta Pace
Elisabetta Pace
MFMaria Ferraro
Maria Ferraro
SVSERENA DI VINCENZO
SERENA DI VINCENZO
CCChiara Cipollina
Chiara Cipollina
SGStefania Gerbino
Stefania Gerbino
MGMark Gjomarkaj
Mark Gjomarkaj
Cigarette smoke extracts (CSE) induce oxidative stress, an important feature in chronic obstructive pulmonary disease (COPD), and oxidative stress contributes to the poor clinical efficacy of corticosteroids in COPD patients. Carbocysteine, an antioxidant and mucolytic agent, is effective in reducing the severity and the rate of exacerbations in COPD patients. The effects of carbocysteine on CSE-induced oxidative stress in bronchial epithelial cells as well as the comparison of these antioxidant effects of carbocysteine with those of fluticasone propionate are unknown. The present study was aimed to assess the effects of carbocysteine (10−4 M) in cell survival and intracellular reactive oxygen species (ROS) production (by flow cytometry) as well as total glutathione (GSH), heme oxygenase-1 (HO-1), nuclear-related factor 2 (Nrf2) expression and histone deacetylase 2 (HDAC-2) expression/activation in CSE-stimulated bronchial epithelial cells (16-HBE) and to compare these effects with those of fluticasone propionate (10−8 M). CSE, carbocysteine or fluticasone propionate did not induce cell necrosis (propidium positive cells) or cell apoptosis (annexin V-positive/propidium-negative cells) in 16-HBE. CSE increased ROS production, nuclear Nrf2 and HO-1 in 16-HBE. Fluticasone propionate did not modify intracellular ROS production, GSH and HDCA-2 but reduced Nrf2 and HO-1 in CSE-stimulated 16-HBE. Carbocysteine reduced ROS production and increased GSH, HO-1, Nrf2 and HDAC-2 nuclear expression/activity in CSE-stimulated cells and was more effective than fluticasone propionate in modulating the CSE-mediated effects. In conclusion, the present study provides compelling evidences that the use of carbocysteine may be considered a promising strategy in diseases associated with corticosteroid resistance.